OGC
CTIC

One68 Global Capital’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

One68 Global Capital’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$126K Buy
+39,116
New +$130K 0.25% 92

Other funds holding CTIC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

One68 Global Capital's CTIC Position: Q4 2020 in Review

One68 Global Capital opened a new position in CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2020: 39,116 shares worth $126K. The stake represents 0.25% of the portfolio and ranks #92 among its holdings.

62 funds tracked by Wall St. Rank hold CTIC as of Q4 2020.

  • One68 Global Capital held 39,116 shares of CTI BioPharma Corp. (DE) Common Stock worth $126K as of Q4 2020.
  • CTI BioPharma Corp. (DE) Common Stock was a new One68 Global Capital position in Q4 2020.
  • CTI BioPharma Corp. (DE) Common Stock made up 0.25% of One68 Global Capital's portfolio in Q4 2020, its #92 holding.
  • 62 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.